Randomised controlled trials (RCTs) Methodologies for a new era summer school School of Applied Social Studies, University College Cork 22 June 2011 Dr.

Slides:



Advertisements
Similar presentations
Appraisal of an RCT using a critical appraisal checklist
Advertisements

Randomized Controlled Trial
Observational Studies and RCT Libby Brewin. What are the 3 types of observational studies? Cross-sectional studies Case-control Cohort.
Study Designs in Epidemiologic
Chapter 3 Flashcards. obligation of an individual to other individuals based on a social or legal contract to justify his or her actions; the processes.
KINE 4565: The epidemiology of injury prevention Randomized controlled trials.
The Bahrain Branch of the UK Cochrane Centre In Collaboration with Reyada Training & Management Consultancy, Dubai-UAE Cochrane Collaboration and Systematic.
Why to Randomize a Randomized Controlled Trial? (and how to do it) John Matthews University of Newcastle upon Tyne.
天 津 医 科 大 学天 津 医 科 大 学 Clinical trail. 天 津 医 科 大 学天 津 医 科 大 学 1.Historical Background 1537: Treatment of battle wounds: 1741: Treatment of Scurvy 1948:
Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2013.
Copyright © 2010, 2007, 2004 Pearson Education, Inc. Chapter 13 Experiments and Observational Studies.
Sampling.
Random and Quasi-random Allocation. Background Surprisingly many researchers do not understand the concept of random allocation. For example, a Professor.
Allocation Methods David Torgerson Director, York Trials Unit
Clinical Trials Hanyan Yang
11 Populations and Samples.
Journal Club Alcohol, Other Drugs, and Health: Current Evidence March–April 2015.
By Dr. Ahmed Mostafa Assist. Prof. of anesthesia & I.C.U. Evidence-based medicine.
An Introduction to Clinical Epidemiology and Research Methodology
Cohort Studies Hanna E. Bloomfield, MD, MPH Professor of Medicine Associate Chief of Staff, Research Minneapolis VA Medical Center.
Experimental Study.
Introduction to evidence based medicine
Experiments and Observational Studies.  A study at a high school in California compared academic performance of music students with that of non-music.
Copyright c 2001 The McGraw-Hill Companies, Inc.1 Chapter 7 Sampling, Significance Levels, and Hypothesis Testing Three scientific traditions critical.
17 June, 2003Sampling TWO-STAGE CLUSTER SAMPLING (WITH QUOTA SAMPLING AT SECOND STAGE)
Study Designs By Az and Omar.
Their contribution to knowledge Morag Heirs. Research Fellow Centre for Reviews and Dissemination University of York PhD student (NIHR funded) Health.
Research Design Interactive Presentation Interactive Presentation
PSYC2030 Exam Review #2 March 13th 2014.
Copyright © 2010 Pearson Education, Inc. Chapter 13 Experiments and Observational Studies.
Experiments and Observational Studies. Observational Studies In an observational study, researchers don’t assign choices; they simply observe them. look.
Lecture 16 (Oct 28, 2004)1 Lecture 16: Introduction to the randomized trial Introduction to intervention studies The research question: Efficacy vs effectiveness.
CLINICAL TRIAL. Clinical Trials Strengths: – Best measure of causal relationship – Best design for controlling bias – Can measure multiple outcomes.
Study Design. Study Designs Descriptive Studies Record events, observations or activities,documentaries No comparison group or intervention Describe.
1 Experimental Study Designs Dr. Birgit Greiner Dep. of Epidemiology and Public Health.
Research Methodology For IB Psychology Students. Empirical Investigation The collecting of objective information firsthand, by making careful measurements.
Systematic Reviews.
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
Understanding real research 4. Randomised controlled trials.
EBM --- Journal Reading Presenter :顏志維 Date : 2005/10/17.
Evidence-Based Medicine Presentation [Insert your name here] [Insert your designation here] [Insert your institutional affiliation here] Department of.
Clinical Writing for Interventional Cardiologists.
CHAPTER 12 Descriptive, Program Evaluation, and Advanced Methods.
Adaptive randomization
Critical appraisal of randomized controlled trial
How to Analyze Therapy in the Medical Literature (part 1) Akbar Soltani. MD.MSc Tehran University of Medical Sciences (TUMS) Shariati Hospital
Evidence Based Practice RCS /9/05. Definitions  Rosenthal and Donald (1996) defined evidence-based medicine as a process of turning clinical problems.
Overview of Study Designs. Study Designs Experimental Randomized Controlled Trial Group Randomized Trial Observational Descriptive Analytical Cross-sectional.
McMillan Educational Research: Fundamentals for the Consumer, 6e © 2012 Pearson Education, Inc. All rights reserved. Educational Research: Fundamentals.
Study designs. Kate O’Donnell General Practice & Primary Care.
© 2006 by The McGraw-Hill Companies, Inc. All rights reserved. 1 Chapter 7 Sampling, Significance Levels, and Hypothesis Testing Three scientific traditions.
Critical Appraisal (CA) I Prepared by Dr. Hoda Abd El Azim.
1 Health and Disease in Populations 2002 Session 8 – 21/03/02 Randomised controlled trials 1 Dr Jenny Kurinczuk.
EBM: Randomized Controlled Trials Gil C. Grimes, MD 10 August 2006.
EVALUATING u After retrieving the literature, you have to evaluate or critically appraise the evidence for its validity and applicability to your patient.
Penn CTSI Research Seminar Clinical Trials November 10, 2015 Vernon M. Chinchilli, PhD Distinguished Professor and Chair Department of Public Health Sciences.
Lecture 2: Evidence Level and Types of Research. Do you recommend flossing to your patients? Of course YES! Because: I have been taught to. I read textbooks.
Types of Studies. Aim of epidemiological studies To determine distribution of disease To examine determinants of a disease To judge whether a given exposure.
Making Randomized Clinical Trials Seem Less Random Andrew P.J. Olson, MD Assistant Professor Departments of Medicine and Pediatrics University of Minnesota.
EVIDENCE-BASED MEDICINE AND PHARMACY 1. Evidence-based medicine 2. Evidence-based pharmacy.
Ten things about Experimental Design AP Statistics, Second Semester Review.
Chapter 2 The Data Analysis Process and Collecting Data Sensibly.
1 Study Design Imre Janszky Faculty of Medicine, ISM NTNU.
Critical Appraisal Course for Emergency Medicine Trainees Module 3 Evaluation of a therapy.
Evidence-Based Mental Health PSYC 377. Structure of the Presentation 1. Describe EBP issues 2. Categorize EBP issues 3. Assess the quality of ‘evidence’
Welcome Clinical Trials October 11, 2016 Vernon M. Chinchilli, PhD
Meeting Monday February 29th 2016.
CLINICAL PROTOCOL DEVELOPMENT
Randomized Trials: A Brief Overview
RCT Workshop, Bushehr 2/16/2019.
Presentation transcript:

Randomised controlled trials (RCTs) Methodologies for a new era summer school School of Applied Social Studies, University College Cork 22 June 2011 Dr Paul Montgomery Jennifer Burton

Aims Questions RCTs might answer Main strengths and weaknesses How to conduct them Different types of RCTs Analysing their results

Questions for RCTs Efficacy Effectiveness (including multiple treatment effects) Harm Mediators Moderators Others?

Levels of evidence (effectiveness studies) 1.Systematic review of several (double-blind) randomised controlled trials 2.One or more large (double-blind) randomised controlled trials 3.One or more well-conducted (large) cohort studies 4.One or more well-conducted case-control studies 5.A dramatic uncontrolled experiment 6.Expert committee sitting in review; peer opinion leader 7.Personal experience (anecdotes)

Randomised Controlled Trials (RCTs) A planned intervention study in which each member of a study population has the same chance of receiving one or more experimental or control treatments Randomisation is the only unique feature of RCTs

Randomised Trial Population Sample Intervention Group Randomisation Control Group Assessment (T 0 ) Intervention Group Control Group Assessment (T 1 )

Why Randomise? Equipoise Internal validity

Why Randomise? Allocation to the comparison groups should be unbiased with respect to prognosis and responsiveness to treatment; it is not determined by the investigators, the clinicians, or the study participants.

Why Randomise? Tends to produce comparable groups. The measured and unmeasured, known and unknown prognostic factors and other characteristics of the participants at the time of randomisation will be, on average, evenly balanced.

Why Randomise? Statistical theories for analysing trials are based on the premise of random sampling Differences between treatment groups behave like the differences between random samples from a single population Randomisation provides a theoretical foundation by which a treatment effect can be estimated and a hypothesis tested without the use of covariate information

Advantages Efficient for investigating causality because ‘cause’ precedes the ‘effect’ Possible confounding factors balanced Randomisation facilitates simple statistical analysis Practical way to minimise several sources of bias (notably, selection bias)

Disadvantages Requires rigorous control of the allocation process Can be long and/or expensive May not be ideal for rare conditions or problems with a long latency Generalisability (often screen out vulnerable groups) Beware the volunteer!

Conducting a RCT Identify the study population Identify the study population (Take baseline measures) (Take baseline measures) Randomly assign participants to the intervention or control group Randomly assign participants to the intervention or control group Provide the intervention (or not) Provide the intervention (or not) Measure outcomes Measure outcomes

Methods of Randomisation Coin toss Pulling numbers out of a hat Random number list l By telephone l Online random allocation (computerised) Sealed envelopes containing allocation numbers (carbonised systems)

Levels and Types Clusters (e.g. Household or classroom) Weighted (e.g. 60% / 40%) Other restrictions l Limitations in service availability l Demographic features

Clustering At what level do you assign participants? l Individual l Group l Area At what level do you measure outcomes?

Clustering School Department Class SS S S S S SS S S S S SS S S S S SS S S S S SS S S S S SS S S S S

Clustered/ Nested Design Benefits l Appropriate for modeling group/area level effects l May facilitate delivery/ reduce contamination Drawbacks l Reduces ability (power) to detect individual level effects

Advanced Types Blocked (groups) Stratified (e.g. to balance gender) Yoked pairs (e.g. Cambridge Somerville) Minimization (control known confounds)

‘Quasi-Randomisation’ Date of birth Day of week Alternating assignment

Selection / Allocation Bias Was group assignment determined randomly or might it have been related to outcomes or the interventions received?

Allocation Bias In non-random studies, group assignment is unlikely to be unbiased In non-random studies, group assignment is unlikely to be unbiased Even in randomised studies, assignment can be influenced unintentionally, fiddled, or result in dissimilar groups Even in randomised studies, assignment can be influenced unintentionally, fiddled, or result in dissimilar groups

Selection/Allocation Bias Sample Intervention Group Selection bias Control Group Assessment (T 0 ) Intervention Group Control Group Intervention Group Control Group T1T1 T2T2

Allocation Concealment Were the practitioner and the client both unaware of the next allocated treatment? Leads to recruitment bias or performance bias Safeguard the assignment sequence before and until allocation

Allocation Bias Trialists can undermine randomisation Whenever possible, studies should l Separate generation and administration of the allocation sequence l Conceal the allocation sequence l Check that allocation concealment was maintained Small groups are frequently unbalanced on baseline variables

Evidence that aspects of design are related to research findings 250 randomised trials from 33 meta-analyses treatment effect 30% to 41% larger in trial without adequate concealment of treatment allocation 17% larger in trials that were not double-blind l Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995 Feb 1;273(5):

Subversion: Why? “RCTS appear to annoy human nature - if properly conducted, indeed they should” Investigators intellectually grasp the concept, but have contradictory interests in clinical practice l trying to get the best treatment for a particular client

Subversion: How? Selecting desired allocation from an open list Holding translucent envelopes to light / opening envelopes Feeling differential weight of envelopes/treatment packages

Subversion: Prevention Randomisation procedure must have methodological safeguards that thwart subversion! Need to minimise selection bias i.e. biased allocation to comparison groups

Allocation Concealment (Schulz, 1995) Shields those who admit patients into a trial from knowing future assignments. l The decision to accept or reject a participant must be made, and informed consent obtained, without knowledge of the treatment to be assigned.

Allocation Concealment Centralised 24 hour telephone hotline (e.g. group assignment by an independent central office) or statistician-controlled randomisation On-site computer system combined with group assignments in a locked unreadable computer file that can be accessed only after entering characteristics of an enrolled subject Sequentially numbered, sealed, opaque envelopes

Allocation v. Blinding Allocation concealment refers to the process of recruitment and assignment to groups and occurs before and during the enrollment process Blinding refers to the knowledge of practitioners, staff, patients, etc. to the actual assignment (i.e. it occurs during and after enrollment)

Blinding Safeguards the assignment sequence after allocation l Users l Practitioners/Clinicians l Assessors Not always possible Financial burden (often requires more staff)

Blinding Consider importance with respect to outcome-level bias l Subjective outcomes (satisfaction) l Objective outcomes (death)

Control Groups What is the control group for? l Time l Attention l ‘Placebo Effect’ Inappropriate control group may threaten blinding l e.g. Active anti-psychotic versus placebo

Types of Comparison Superiority Non-Inferiority

Measuring Outcomes Usually easy! Continuous l Means and SDs l ANOVA Dichotomous l T-test (Effect sizes)

You should be familiar with ConSORT Checklist & Elaboration paper l Extensions l Cluster trials l Non-inferiority l Etc. See also The EQUATOR Network l

More on Bias… Delgado 2004 Critical Appraisal Sheets from the Centre for Evidence-Based Medicine